跳至主要内容
临床试验/IRCT20180506039558N1
IRCT20180506039558N1招募中3 期

Effect of Intravenous Dexmedetomidine on Inflammatory factors in Patients undergoing Total Abdominal Hysterectomy

Ahvaz University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 65 years(—)
性别
Female

入选标准

  • Female candidate of Total Abdominal Hysterectomy (TAH)
  • Body mass index (BMI): 18 to 40 kg/m2
  • American Society of Anesthesiologists (ASA) classification I , II

排除标准

  • Allergic reaction to Dexmedetomidine
  • History of Dexmedetomidine administration over the past week
  • History of heart, lung, liver, and kidney diseases
  • Patients with neurological or neuromuscular disorders
  • Patients with anemia or bleeding disorders
  • Consumption of Alcohol, narcotic and Antipsychotic medications
  • Patients with diabetes

研究者

相似试验

Intravenous Dexmedetomidine on Inflammatory... | 临床试验